GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3

Company

Addex Therapeutics Ltd.

Filed

November 28, 2022

Accession Number

0001072613-22-000649